Department of Cardiovascular Medicine, Faculty of Medicine, Assiut University, P.Box. 71526, Assiut, Egypt.
Department of Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt.
BMC Cardiovasc Disord. 2022 Sep 6;22(1):396. doi: 10.1186/s12872-022-02833-0.
Myocarditis is a highly heterogeneous disorder with a challenging diagnostic work-up. We aimed to focus on the possible diagnostic workup for this condition in settings where endomyocardial biopsy as a gold standard is not always feasible, detect the etiologic cardiotropic viruses in our locality, and follow the clinical course in patients admitted with clinically suspected myocarditis.
This is a prospective observational study. We recruited patients with clinically suspected myocarditis presenting at a university hospital from October 1st, 2020 until March 31st, 2021. All Patients had a diagnostic coronary angiography and were included only if they had a non-obstructive coronary artery disease. All patients also had cardiac magnetic resonance imaging (CMR) with contrast. Sera were obtained from all suspected patients for detection of antibodies against viruses using enzyme-linked immunosorbent assay, and viral genomes using polymerase chain reaction (PCR), and reverse transcription-PCR. Endomyocardial biopsy was done for patients with a typical CMR picture of myocarditis.
Out of 2163 patients presenting to the hospital within the 6 months, only 51 met the inclusion criteria. Males represented 73%, with a mean age of 39 ± 16 years. CMR showed an ischemic pattern in 4 patients and thus they were excluded. We classified patients into two categories based on CMR results: group A (CMR-positive myocarditis), 12 patients (25.5%), and group B (CMR-negative myocarditis), 35 (74.5%) patients. On serological analysis, 66% of patients (n = 31/47) showed antibodies against the common cardiotropic viruses. Parvovirus B19 IgM in 22 patients (47%) and coxsackievirus IgM in 16 (34%) were the most observed etiologies. Regarding the outcome, 42.5% of patients recovered left ventricular ejection fraction and three patients died at 6 months' clinical follow-up.
Patients with Clinically suspected myocarditis represented 2.2% of total hospital admissions in 6 months. CMR is only a good positive test for the diagnosis of acute myocarditis. Parvovirus B19 and coxsackievirus were the most common pathogens in our locality.
Clinical trial registration no., NCT04312490; first registration: 18/03/2020. First recruited case 01/10/2020. URL: https://register.
gov/prs/app/action/SelectProtocol?sid=S0009O3D&selectaction=Edit&uid=U0002DVP&ts=2&cx=9zdfin .
心肌炎是一种高度异质性疾病,其诊断过程极具挑战性。我们旨在关注在无法进行作为金标准的心肌活检的情况下,该疾病可能的诊断方法,检测我们当地的致心脏病毒性病毒,并对临床上疑似心肌炎的患者进行临床随访。
这是一项前瞻性观察性研究。我们招募了 2020 年 10 月 1 日至 2021 年 3 月 31 日在一所大学医院就诊的临床上疑似心肌炎的患者。所有患者均进行了诊断性冠状动脉造影检查,且仅在冠状动脉无阻塞性疾病的情况下纳入研究。所有患者还接受了心脏磁共振成像(CMR)检查,包括对比剂。从所有疑似患者中采集血清样本,采用酶联免疫吸附试验检测病毒抗体,采用聚合酶链反应(PCR)和逆转录-PCR 检测病毒基因组。对 CMR 表现为典型心肌炎的患者进行心内膜心肌活检。
在 6 个月内就诊的 2163 例患者中,仅有 51 例符合纳入标准。男性占 73%,平均年龄 39±16 岁。4 例患者的 CMR 显示缺血模式,因此被排除在外。我们根据 CMR 结果将患者分为两类:CMR 阳性心肌炎组(A 组),12 例(25.5%);CMR 阴性心肌炎组(B 组),35 例(74.5%)。血清学分析显示,66%的患者(n=31/47)存在针对常见致心脏病毒性病毒的抗体。22 例(47%)患者存在细小病毒 B19 IgM,16 例(34%)患者存在柯萨奇病毒 IgM。6 个月临床随访时,42.5%的患者左心室射血分数恢复正常,3 例患者死亡。
临床上疑似心肌炎的患者占 6 个月内总住院人数的 2.2%。CMR 仅对急性心肌炎的诊断有良好的阳性预测价值。细小病毒 B19 和柯萨奇病毒是本地区最常见的病原体。
临床试验注册号,NCT04312490;首次注册日期,2020 年 3 月 18 日;首次入组日期,2020 年 10 月 1 日。网址:https://register.
gov/prs/app/action/SelectProtocol?sid=S0009O3D&selectaction=Edit&uid=U0002DVP&ts=2&cx=9zdfin。